S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83

U.S. Physical Therapy Stock Forecast, Price & News

+1.48 (+1.55%)
(As of 12/7/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
143,142 shs
Average Volume
68,959 shs
Market Capitalization
$1.25 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive USPH News and Ratings via Email

Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.

U.S. Physical Therapy logo

About U.S. Physical Therapy

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics, which provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. The company operates through the following segments: physical therapy operations and industrial injury prevention services. The physical therapy operations segment consist of physical therapy and occupational therapy clinics that provide pre-and postoperative care and treatment for orthopedic related disorders, sports-related injuries, preventive care, rehabilitation of injured workers and neurological injuries. The injury prevention services segment includes onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. U.S. Physical Therapy was founded in 1990 and is headquartered in Houston, TX.


U.S. Physical Therapy (NYSE:USPH) Hits New 1-Year Low at $87.75
November 26, 2021 |  americanbankingnews.com
U.S. Physical Therapy (NYSE:USPH) Stock Price Up 6.4%
November 22, 2021 |  americanbankingnews.com
U.S. Physical Therapy (NYSE:USPH) Rating Increased to Buy at Sidoti
November 22, 2021 |  americanbankingnews.com
U.S. Physical Therapy (NYSE:USPH) Trading Down 4.8%
November 19, 2021 |  americanbankingnews.com
U.S. Physical Therapy (NYSE:USPH) Sets New 52-Week Low at $97.83
November 15, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Health services
Health Care Facilities
Year Founded

Sales & Book Value

Annual Sales
$422.97 million
Cash Flow
$4.14 per share
Book Value
$22.51 per share


Net Income
$35.19 million
Pretax Margin




Free Float
Market Cap
$1.25 billion

Company Calendar

Last Earnings
Dividend Payable
Fiscal Year End
Next Earnings (Estimated)


Overall MarketRank

2.93 out of 5 stars

Medical Sector

39th out of 1,394 stocks

Health Services Industry

1st out of 15 stocks

Analyst Opinion: 3.5Community Rank: 3.9Dividend Strength: 4.2Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -

U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions

Is U.S. Physical Therapy a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" U.S. Physical Therapy stock.
View analyst ratings for U.S. Physical Therapy
or view top-rated stocks.

How has U.S. Physical Therapy's stock been impacted by COVID-19?

U.S. Physical Therapy's stock was trading at $93.22 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, USPH shares have increased by 3.8% and is now trading at $96.79.
View which stocks have been most impacted by COVID-19

When is U.S. Physical Therapy's next earnings date?

U.S. Physical Therapy is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for U.S. Physical Therapy

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) posted its quarterly earnings results on Thursday, November, 4th. The company reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.78 by $0.07. The firm earned $125.90 million during the quarter, compared to analyst estimates of $124.67 million. U.S. Physical Therapy had a net margin of 6.64% and a trailing twelve-month return on equity of 16.63%. U.S. Physical Therapy's revenue for the quarter was up 15.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.86 EPS.
View U.S. Physical Therapy's earnings history

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy announced a quarterly dividend on Tuesday, November 2nd. Stockholders of record on Monday, November 15th will be paid a dividend of $0.38 per share on Friday, December 10th. This represents a $1.52 annualized dividend and a yield of 1.57%. The ex-dividend date of this dividend is Friday, November 12th.
View U.S. Physical Therapy's dividend history

Is U.S. Physical Therapy a good dividend stock?

U.S. Physical Therapy pays an annual dividend of $1.52 per share and currently has a dividend yield of 1.59%. U.S. Physical Therapy has been increasing its dividend for 10 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of U.S. Physical Therapy is 64.14%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, U.S. Physical Therapy will have a dividend payout ratio of 46.77% next year. This indicates that U.S. Physical Therapy will be able to sustain or increase its dividend.
View U.S. Physical Therapy's dividend history.

What price target have analysts set for USPH?

3 analysts have issued 1-year price targets for U.S. Physical Therapy's shares. Their forecasts range from $135.00 to $139.00. On average, they anticipate U.S. Physical Therapy's share price to reach $137.00 in the next twelve months. This suggests a possible upside of 41.5% from the stock's current price.
View analysts' price targets for U.S. Physical Therapy
or view top-rated stocks among Wall Street analysts.

Who are U.S. Physical Therapy's key executives?

U.S. Physical Therapy's management team includes the following people:
  • Christopher J. Reading, President, Chief Executive Officer & Director
  • Graham Reeve, Chief Operating Officer-East Region (LinkedIn Profile)
  • Carey P. Hendrickson, Chief Financial Officer
  • Chadd Pence, Vice President-Information Systems
  • Jayne Fleck Pool, Chief Compliance Officer & VP-Clinical Services

What is Chris Reading's approval rating as U.S. Physical Therapy's CEO?

38 employees have rated U.S. Physical Therapy CEO Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among U.S. Physical Therapy's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.67%), Kayne Anderson Rudnick Investment Management LLC (12.05%), Boston Trust Walden Corp (3.40%), Dimensional Fund Advisors LP (2.97%), Copeland Capital Management LLC (2.45%) and Wasatch Advisors Inc. (1.89%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Edward L Kuntz, Glenn Mcdowell, Graham D Reeve, Graham D Reeve, Harry S Chapman, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson.
View institutional ownership trends for U.S. Physical Therapy

Which major investors are selling U.S. Physical Therapy stock?

USPH stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Goldman Sachs Group Inc., Millennium Management LLC, Wasatch Advisors Inc., Peregrine Capital Management LLC, Voloridge Investment Management LLC, Bridge City Capital LLC, and Alliancebernstein L.P.. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Edward L Kuntz, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Lawrance W Mcafee, and Mark J Brookner.
View insider buying and selling activity for U.S. Physical Therapy
or view top insider-selling stocks.

Which major investors are buying U.S. Physical Therapy stock?

USPH stock was purchased by a variety of institutional investors in the last quarter, including Ensign Peak Advisors Inc, Copeland Capital Management LLC, State of New Jersey Common Pension Fund D, Johnson Investment Counsel Inc., Morgan Stanley, Aviva PLC, Crawford Investment Counsel Inc., and Boston Trust Walden Corp. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, Kathleen A Gilmartin, and Regg E Swanson.
View insider buying and selling activity for U.S. Physical Therapy
or or view top insider-buying stocks.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $96.79.

How much money does U.S. Physical Therapy make?

U.S. Physical Therapy has a market capitalization of $1.25 billion and generates $422.97 million in revenue each year. The company earns $35.19 million in net income (profit) each year or $2.37 on an earnings per share basis.

How many employees does U.S. Physical Therapy have?

U.S. Physical Therapy employs 4,630 workers across the globe.

What is U.S. Physical Therapy's official website?

The official website for U.S. Physical Therapy is www.usph.com.

Where are U.S. Physical Therapy's headquarters?

U.S. Physical Therapy is headquartered at 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at (713) 297-7000, via email at [email protected], or via fax at 713-297-7090.

This page was last updated on 12/8/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.